Yuki Gosei Kogyo Co., Ltd.

Tokyo Stock Exchange 4531.T

Yuki Gosei Kogyo Co., Ltd. Net Income for the year ending March 31, 2024: USD 5.13 M

Yuki Gosei Kogyo Co., Ltd. Net Income is USD 5.13 M for the year ending March 31, 2024, a 22.51% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.
  • Yuki Gosei Kogyo Co., Ltd. Net Income for the year ending March 31, 2023 was USD 4.19 M, a 105.42% change year over year.
  • Yuki Gosei Kogyo Co., Ltd. Net Income for the year ending March 31, 2022 was USD 2.04 M, a -21.66% change year over year.
  • Yuki Gosei Kogyo Co., Ltd. Net Income for the year ending March 31, 2021 was USD 2.60 M, a 765.88% change year over year.
  • Yuki Gosei Kogyo Co., Ltd. Net Income for the year ending March 31, 2020 was USD -390.56 K, a -141.64% change year over year.
Key data
Date Net Income EPS (Diluted) Shares (Diluted, Weighted) Net Income Margin
Market news
Loading...
SV Wall Street
Tokyo Stock Exchange: 4531.T

Yuki Gosei Kogyo Co., Ltd.

CEO Seiichiro Matsumoto
IPO Date Jan. 4, 2001
Location Japan
Headquarters 10-4, Nihonbashi-Ningyocho 3-chome
Employees 290
Sector Materials
Industries
Description

Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufacturing of pharmaceuticals and chemical products. Yuki Gosei Kogyo Co., Ltd. was founded in 1947 and is headquartered in Tokyo, Japan.

StockViz Staff

February 2, 2025

Any question? Send us an email